Page 1,024«..1020..1,0231,0241,0251,026..1,0301,040..»

2 Your Well-Being Webchat: Heart Health – WFMYNews2.com

Posted: Published on February 18th, 2020

GREENSBORO, N.C. Its all about matters of the heart! Join WFMY News 2 for a 2 Your Well-Being Heart Health live webchat at 3:00 p.m. on Wednesday, February 19, 2020. Continue reading →

Posted in Clinical Cardiology | Comments Off on 2 Your Well-Being Webchat: Heart Health – WFMYNews2.com

Endotronix Announces Enrollment of the First Patients in the PROACTIVE-HF Pivotal Trial – Yahoo Finance

Posted: Published on February 18th, 2020

Study to support U.S. Continue reading →

Posted in Clinical Cardiology | Comments Off on Endotronix Announces Enrollment of the First Patients in the PROACTIVE-HF Pivotal Trial – Yahoo Finance

Lower ST Levels in Lateral ECG Leads Found to Be Associated With All-Cause Mortality – The Cardiology Advisor

Posted: Published on February 18th, 2020

Lower ST levels in electrocardiogram (ECG) lateral leads were found to be independently associated with all-cause mortality, according to a study published in the Journal of Electrocardiology. Slight ST depression even slight depressions on ECG has been linked to cardiovascular disease and poorer outcomes. However, population-level studies in which the prognostic significance of ST-level changes have been examined are lacking, with few studies examining ST slope or ST level as a continuous variable Continue reading →

Posted in Clinical Cardiology | Comments Off on Lower ST Levels in Lateral ECG Leads Found to Be Associated With All-Cause Mortality – The Cardiology Advisor

[Grey zones on new oral anticoagulants in atrial fibrillation. Expert opinion]. – Physician’s Weekly

Posted: Published on February 18th, 2020

Clinical guidelines, while representing an objective reference to perform appropriate treatment choices, contain grey zones, where recommendations are not supported by solid evidence. In a conference held in Bergamo in October 2018, an attempt was made to highlight some of the main grey zones in Cardiology and, through a comparison between experts, to draw shared conclusions that can illuminate our clinical practice Continue reading →

Posted in Clinical Cardiology | Comments Off on [Grey zones on new oral anticoagulants in atrial fibrillation. Expert opinion]. – Physician’s Weekly

Clinical Trial Supplies Market 2020 Present Scenario, Technology and Scope of Current and Future Industry 2020-2026 – News Times

Posted: Published on February 18th, 2020

The Clinical Trial Supplies Market report offers a detailed analysis of Industry with growth & significant CAGR during forecast period 2020-2026 by top Key manufacturers analysis, region, Types, and Market segment by Applications. This Clinical Trial Supplies market research report is conducted to understand the current landscape of the Global market, especially in 2020. Continue reading →

Posted in Clinical Cardiology | Comments Off on Clinical Trial Supplies Market 2020 Present Scenario, Technology and Scope of Current and Future Industry 2020-2026 – News Times

University Hospitals recruits Alejandro Rivas, MD, as the New Division Chief of Otology/Neurotology – Newswise

Posted: Published on February 18th, 2020

MEDIA CONTACT Available for logged-in reporters only Newswise CLEVELAND -- University Hospitals (UH) has appointed Alejandro Rivas, M.D., to be Division Chief of Otology/Neurotology in the UH Department of Otolaryngology-Head and Neck Surgery. He joins UH on June 1, 2020 from Vanderbilt University Medical Center in Nashville, Tenn., where he is Director of Endoscopic Ear Surgery Nicole Maronian, MD, Chair, UH Department of Otolaryngology Head and Neck Surgery, said, Dr Continue reading →

Posted in Clinical Cardiology | Comments Off on University Hospitals recruits Alejandro Rivas, MD, as the New Division Chief of Otology/Neurotology – Newswise

Study: Women evaluate partners more negatively when estrogen is elevated and men know it – PsyPost

Posted: Published on February 17th, 2020

New research provides evidence that natural fluctuations in womens hormones are not only associated with their own psychology, but also their partners perception and well-being. The study, published in Biological Psychology, was the first to examine how the rise and fall of womens hormones during the menstrual cycle impacts their partners feelings and perceptions. Continue reading →

Posted in Testosterone | Comments Off on Study: Women evaluate partners more negatively when estrogen is elevated and men know it – PsyPost

Biologic And Medical Imaging Reagents Market to Make Great Impact in near Future by -2022 – Kentucky Journal 24

Posted: Published on February 17th, 2020

The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022. Report Scope: Topics covered in this report include: Fluorescent dyes and probes. Continue reading →

Posted in Molecular Cardiology | Comments Off on Biologic And Medical Imaging Reagents Market to Make Great Impact in near Future by -2022 – Kentucky Journal 24

The Best Eczema Creams to Try This Winter, According to the Pros – Vogue

Posted: Published on February 17th, 2020

Photo-Illustration: Ivana Cruz / Photo Courtesy of: Cory Vanderploge & Gallery Stock Whether its the persistently dry and itchy patches on the hands and arms, or the flaky red skin on the neck and face, eczema, also known as dermatitis, can be relentless. Its a very common itchy, inflammatory skin condition that affects children and adults, explains Peter Lio, MD, board-certified dermatologist and National Eczema Association scientific advisory board member. Continue reading →

Posted in Eczema | Comments Off on The Best Eczema Creams to Try This Winter, According to the Pros – Vogue

Eli Lilly and Incyte Record Another Positive Clinical Trial for Olumiant Works in Eczema – The Motley Fool

Posted: Published on February 17th, 2020

Eli Lilly (NYSE:LLY) and Incyte (NASDAQ:INCY) are marching forward in their quest to gain regulatory approval for Olumiant as a treatment for atopic dermatitis (AD), commonly referred to as eczema. https://www.globenewswire.com/news-release/2020/02/11/1983486/0/en/Lilly and-Incyte-Announce-Positive-Top-Line-Results-from-the-North-American-Phase-3-Study-BREEZE-AD5-of-Oral-Selective-JAK-Inhibitor-Baricitinib-in-Patients-with-Moderate-to-Severe.html Last month, the companies showedthat the drug in combination with topical corticosteroids helped patients reduce their eczema symptoms Continue reading →

Posted in Eczema | Comments Off on Eli Lilly and Incyte Record Another Positive Clinical Trial for Olumiant Works in Eczema – The Motley Fool

Page 1,024«..1020..1,0231,0241,0251,026..1,0301,040..»